Back to Search Start Over

Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agents.

Authors :
Othman, Tamer A.
Mei, Matthew
Zhang, Jianying
Aldoss, Ibrahim
Stein, Anthony
Forman, Stephen J.
Marcucci, Guido
Pullarkat, Vinod
Source :
American Journal of Hematology; May2021, Vol. 96 Issue 5, pE140-E143, 4p
Publication Year :
2021

Details

Language :
English
ISSN :
03618609
Volume :
96
Issue :
5
Database :
Complementary Index
Journal :
American Journal of Hematology
Publication Type :
Academic Journal
Accession number :
149784566
Full Text :
https://doi.org/10.1002/ajh.26117